Cardiac alterations in human African trypanosomiasis (T.b. gambionse) with respect to the disease stage and antiparasitic treatment

PLoS Neglected Tropical Diseases

Volumn 3, Issue 2, 2009, Pages

  Blum, Johannes A ^a   Schmid, Caecilia ^a   Burri, Christian ^a   Hatz, Christoph ^a   Olson, Carol ^b   Fungula, Blaise ^c   Kazumba, Leon ^d   Mangoni, Patrick ^c   Mbo, Florent ^e   Deo, Kambau ^f   Mpanya, Alain ^g   Dala, Amadeo ^h   Franco, Jose R ^i,k   Pohlig, Gabriele ^a   Zellweger, Michael J ^j  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b Immtech Pharmaceuticals Inc   (United States)

^c Hôpital Evangélique de Vanga   (Congo)

^d Centre Neuro Psycho Pathologique   (Congo)

^e Hôpital General de Reference Bandundu   (Congo)

^f Hôpital Evangélique de Kikongo   (Congo)

^g CDTC Maluku ^*  (Congo)

^h Instituto de Combate e Controlo das Tripanossomiases   (Angola)

ⁱ Malteser Hospital   (Sudan)

^j UNIVERSITY HOSPITAL BASEL   (Switzerland)

^k WORLD HEALTH ORGANIZATION   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; CHLOROQUINE; EFLORNITHINE; FANSIDAR; MELARSOPROL; PAFURAMIDINE; PENTAMIDINE; QUININE; ANTITRYPANOSOMAL AGENT;

ADULT; AFRICAN TRYPANOSOMIASIS; ANGOLA; ARTICLE; CONGO; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAM; FEMALE; HEART DISEASE; HEART REPOLARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALE; QT PROLONGATION; SKIN LEISHMANIASIS; SUDAN; TRYPANOSOMA GAMBIENSE; VOLUNTEER; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ELECTROCARDIOGRAPHY; HEART; HEART ARRHYTHMIA; PATHOLOGY; PATHOPHYSIOLOGY;

ADULT; ARRHYTHMIAS, CARDIAC; ELECTROCARDIOGRAPHY; FEMALE; HEART; HEART DISEASES; HUMANS; MALE; TRYPANOCIDAL AGENTS; TRYPANOSOMIASIS, AFRICAN;

EID: 65549148546     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000383     Document Type: Article

References (33)

1. Blum J, Schmid C, Burri C (2006) Clinical aspects of 2541 patients with second stage human African trypanosomiasis. Acta Trop 97: 55-64.
2. Adams JH, Haller L, Boa FY, Doua F, Dago A, Konian K (1986) Human African trypanosomiasis (T.b. gambiense): a study of 16 fatal cases of sleeping sickness with some observations on acute reactive arsenical encephalopathy. Neuropathol Appl Neurobiol 12: 81-94.
3. Collomb H, Bartoli D (1967) [The heart in human African trypanosomiasis caused by Trypanosoma gambiense]. Bull Soc Pathol Exot Filiales 60: 142-156.
4. Blum JA, Burri C, Hatz C, Kazumba L, Mangoni P, Zellweger MJ (2007) Sleeping hearts: the role of the heart in sleeping sickness (human African trypanosomiasis). Trop Med Int Health 12: 1422-1432.
5. Fouchet M, Gateff C (1968) [Development of cardiovascular involvement in African trypanosomiasis due to Trypanosoma gambiense]. Med Trop (Mars) 28: 583-590.
6. Bertrand E, Serie F, Rive J, Compaore P, Sentilhes L, Baudin L, Renambot J, Chauvet J, Ekra A, Assamoi MO (1974) [Current aspects of the cardiac symptoms in African human trypanosomiasis due to Trypanosoma gambiense (apropos of 194 cases)]. Acta Cardiol 29: 363-381.
7. Tsala MP, Blackett K, Mbonifor CL, Leke R, Etoundi J (1988) [Functional and immunologic involvement in human African trypanosomiasis caused by Trypanosoma gambiense]. Bull Soc Pathol Exot Filiales 81: 490-501.
8. Kuryshev YA, Ficker E, Wang L, Hawryluk P, Dennis AT, Wible BA, Brown AM, Kang J, Chen XL, Sawamura K, Reynolds W, Rampe D (2005) Pentamidine-induced long QT syndrome and block of hERG trafficking. J Pharmacol Exp Ther 312: 316-323.
9. Jones IG, Lowenthal MN, Buyst H (1975) Electrocardiographic changes in African trypanosomiasis caused by Trypanosoma brucei rhodesiense. Trans R Soc Trop Med Hyg 69: 388-395.
10. De Raadt P, Koten JW (1968) Myocarditis in Rhodesiense trypanosomiasis. East Afr Med J 45: 128-132.
11. Koten JW, De Raadt P (1969) Myocarditis in Trypanosoma rhodesiense infections. Trans R Soc Trop Med Hyg 63: 485-489.
12. Bertrand E, Sentilhes L, Ducasse B, Vacher P, Baudin L (1965) [Heart involvement in African trypanosomiasis due to Trypanosoma gambiense. Apropos of especially the ECG verifications in 60 patients]. Med Trop (Mars) 25: 603-611.
13. Bertrand E, Baudin L, Vacher P, Sentilhes L, Ducasse B, Veyret V (1967) [Impairment of the heart in 100 cases of African trypanosomiasis due to Trypanosoma gambiense]. Bull Soc Pathol Exot Filiales 60: 360-369.
14. Bertrand E, Sentilhes L, Ducasse M, Vacher P, Baudin L, Serie F (1966) [Systematic study of the electrocardiogram in African trypanosomiasis due to Trypanosoma gambiense. (Apropos of 60 patients)]. Arch Mal Coeur Vaiss 59: 1220-1234.
15. Burri C, Nkunku S, Merolle A, Smith T, Blum J, Brun R (2000) Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial. Lancet 355: 1419-1425.
16. Blum J, Burri C (2002) Treatment of late stage sleeping sickness caused by T.b. gambiense: a new approach to the use of an old drug. Swiss Med Wkly 132: 51-56.
17. Chappuis F, Udayraj N, Stietenroth K, Meussen A, Bovier PA (2005) Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis. Clin Infect Dis 41: 748-751.
18. Al Khatib SM, LaPointe NM, Kramer JM, Califf RM (2003) What clinicians should know about the QT interval. JAMA 289: 2120-2127.
19. Moss AJ (1993) Measurement of the QT interval and the risk associated with QTc interval prolongation: a review. Am J Cardiol 72: 23B-25B.
20. Wang K, Asinger RW, Marriott HJ (2003) ST-segment elevation in conditions other than acute myocardial infarction. N Engl J Med 349: 2128-2135.
21. White NJ (1988) Drug treatment and prevention of malaria. Eur J Clin Pharmacol 34: 1-14.
22. Luzzi GA, Peto TE (1993) Adverse effects of antimalarials. An update. Drug Saf 8: 295-311.
23. Luzzi GA, Peto TE (1993) Adverse effects of antimalarials. An update. Drug Saf 8: 295-311.
24. Bertrand E, Serie F, Kone I, Rive J, Campaore P, Sentilhes L, Philippe J (1973) Symptomatologie générale de la trypanosomiase humaine africaine au moment du dépistage. Médecine d'Afrique Noire 20: 303-314.
25. Poltera AA, Sayer PD, Rudin W, Bovell D (1985) Trypanosomal cardiac valvulitis in vervet monkeys. Trop Med Parasitol 36: 77-80.
26. Poltera AA, Sayer PD (1983) Cardiac lymph drainage in experimental African trypanosomiasis in vervet monkeys. Bull Soc Pathol Exot Filiales 76: 614-621.
27. Poltera AA (1980) Immunopathological and chemotherapeutic studies in experimental trypanosomiasis with special reference to the heart and brain. Trans R Soc Trop Med Hyg 74: 706-715.
28. Costello-Boerrigter LC, Boerrigter G, Redfield MM, Rodeheffer RJ, Urban LH, Mahoney DW, Jacobsen SJ, Heublein DM, Burnett JC Jr (2006) Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction. J Am Coll Cardiol 47: 345-353.
29. Damian MS, Dorndorf W, Burkardt H, Singer I, Leinweber B, Schachenmayr W (1994) [Polyneuritis and myositis in Trypanosoma gambiense infection]. Dtsch Med Wochenschr 119: 1690-1693.
30. Croft AM, Jackson CJ, Friend HM, Minton EJ (2006) African trypanosomiasis in a British soldier. J R Army Med Corps 152: 156-160.
31. Poltera AA, Cox JN, Owor R (1976) Pancarditis affecting the conducting system and all valves in human African trypanosomiasis. Br Heart J 38: 827-837.
32. Poltera AA, Hochmann A, Lambert PH (1980) A model for cardiopathy induced by Trypanosoma brucei brucei in mice. A histologic and immunopathologic study. Am J Pathol 99: 325-351.
33. Poltera AA, Hochmann A, Lambert PH (1981) Trypanosoma brucei brucei: the response to Melarsoprol in mice with cerebral trypanosomiasis. An immunopathological study. Clin Exp Immunol 46: 363-374.